Last 17,450 KRW
Change Today 0.00 / 0.00%
Volume 95.4K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 1:15 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

View Cash Flow In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2010
Press
Release

KRW
Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
4 Year
Trend
NET INCOME--9,436.49,614.812,320.9
(Gain) Loss from Sale of Asset--115.110.6172.0
(Gain) Loss on Sale of Investment--64.9737.763.5
Asset Writedown & Restructuring Costs--600.0747.3766.1
Provision & Write-off of Bad Debts--687.6440.4140.5
Change in Accounts Receivable--1,710.61,876.41,220.5
Change in Inventories---2,369.2-4,545.0-6,026.6
Change in Accounts Payable--2,612.51,300.1-12.6
Change in Other Working Capital--4,433.6-4,625.2-4,927.0
CASH FROM OPERATIONS--17,932.713,827.712,320.5
Capital Expenditure---10,155.9-3,303.2-9,848.9
Sale of Property, Plant, and Equipment--12.02.716.2
Sale (Purchase) of Real Estate Properties---35.6----
Sale (Purchase) of Intangible Assets---1,130.9-44.6-133.8
CASH FROM INVESTING---13,822.9-3,547.2-16,796.9
Short-Term Debt Issued--3,080.6----
Short Term Debt Repaid---3,000.0-3,200.0--
Common and/or Preferred Dividends Paid---2,458.9-637.9-701.7
TOTAL DIVIDEND PAID---2,458.9-637.9-701.7
CASH FROM FINANCING---1,655.0-3,875.0-509.4
Foreign Exchange Rate Adjustments---0.8-0.1--
Miscellaneous Cash Flow Adjustments--0.00.00.0
NET CHANGE IN CASH--2,454.16,405.4-4,985.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 17,450.00 KRW 0.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 18.6x
Price/Sales 1.6x
Price/Book 2.1x
Price/Cash Flow 18.5x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.